✦ LIBER ✦

Orphan/rare drug discovery through drug repositioning

✍ Scribed by Ramaiah Muthyala

Book ID: 119226218
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 114 KB
Volume: 8
Category: Article
ISSN: 1740-6773
DOI: 10.1016/j.ddstr.2011.10.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug repositioning for orphan diseases

✍ Sardana, D.; Zhu, C.; Zhang, M.; Gudivada, R. C.; Yang, L.; Jegga, A. G. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 131 KB

Orphan nuclear receptors in drug discove

Orphan nuclear receptors in drug discovery

✍ Yanhong Shi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Rare diseases and orphan drugs

✍ Melnikova, Irena 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 327 KB

Rare diseases and orphan drugs

✍ J. K. Aronson 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Alternative drug discovery approaches fo

Alternative drug discovery approaches for orphan GPCRs

✍ Angélique Levoye; Ralf Jockers 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 572 KB

Discovery Laboratories: European orphan

Discovery Laboratories: European orphan drug for Surfaxin

📂 Article 📅 2002 🏛 Elsevier Science ⚖ 31 KB

scheduled to start up in 1H 2006. It will produce 85,000 tonnes/y ethoxylates, 20,000 tonnes/y of methyl diethanolamine and di-methyl ethanolamine, 150,000 tonnes/y of ethylene oxide, 100,000 tonnes/y of ethanolamines, 50,000 tonnes/y of methylamine, 50,000 tonnes/y of dimethyl formamide and 15,000